The structural co-ordinates reported for EML2 11-60 and EML4 6-64 I38M appear in the PDB under codes 4CGB and 4CGC respectively. ! 2!
INTRODUCTION
Microtubules (MTs) are polymers of tubulin heterodimers that form a dynamic network as part of the eukaryotic cytoskeleton. They carry out many essential cellular processes including forming an intracellular transport system for RNAs, proteins and organelles and regulating cell motility and changes in cell shape [1, 2] . In mitosis, MTs form the spindle apparatus that segregates chromosomes into two equal sets. The dynamic nature of MTs -their stochastic growth and shrinkage -is crucial for their function and is regulated by MT-associated proteins (MAPs) [3] .
The present work is focused on the echinoderm MT-associated protein (EMAP)-like (EML) family of MAPs. The archetypal member of this family was identified as the most abundant MAP in dividing echinoderm eggs and embryos [4] . Further members of the EML family associate with MTs and are essential for the proper formation of both the interphase MT network and the mitotic spindle [5] [6] [7] [8] . EML proteins affect microtubule dynamics, and may act as scaffold proteins to localize mitotic kinases to MTs [5, 9, 10] . Drosophila and C. elegans each have a single EML homologue, whereas six EML proteins are present in humans of which EML1-4 have molecular weights in the 70-120 kDa range while EML5 and 6 are in excess of 200 kDa. The EML proteins contain WD40 repeats, and in EML1-4 these fall within a ~70 kDa core region that begins with a conserved ~60 amino acid sequence that has been termed the 'hydrophobic EML protein' (HELP) motif [5] . We recently determined the crystal structure of the core HELP/WD region of human EML1, which forms a tandem atypical β-propeller (TAPE) domain that binds soluble tubulin! [11] . Most splice variants of EML1-4 are also predicted to contain a coiled-coil in the N-terminal region.
Rearrangements in the short arm of chromosome 2 leading to genetic fusions between EML4 and the gene encoding anaplastic lymphoma kinase (ALK) occur in ~5% of cases of nonsmall cell lung cancer (NSCLC) [12] . Multiple variants of the EML4-ALK fusion have been identified in NSCLC resulting from translocations at different points within the EML4 gene [13] . A similar genetic fusion has also been reported between EML1 and the gene encoding another tyrosine kinase Abelson 1 (ABL1) in T-cell acute lymphoblastic leukaemia [14] . These fusions have potent transforming activity due to constitutive activation of the tyrosine kinase but confer addiction to the oncogene and inhibition of the tyrosine kinase induces apoptosis in transformed cells [15, 16] . Transforming activity of EML4-ALK variant 1 is dependent on the N-terminal region, and this is proposed to be due to oligomerization of ALK [12] . Indeed, this hypothesis appears to be confirmed by the identification of EML4-ALK variant 5, which encodes just the N-terminal region up to the end of the predicted coiled-coil [17] .
In this study we determined the crystal structure of the N-terminal region of EML proteins that is required to drive the transforming capability of EML4-ALK fusions and reveal a trimeric state of oligomerization. We then investigated the role of this coiled-coil in MT binding in both EML proteins and oncogenic EML-kinase fusions.
MATERIALS AND METHODS

Gene manipulation
Human EML cDNAs were cloned by PCR from human cDNA (Clontech). Products encoding EML4 6-64 and EML2 isoform 2 11-60 were amplified by PCR and cloned into a modified version of pET30. Constructs were made comprising EML1 residues 167-815 (TAPE domain), 1-174 (N-terminus), 23-78 (TD) and 80-815 (Δ-TD). The EML1 AAAA mutant contained the mutations L59A and D61A. Cloning of EML1-ABL1 and EML4-ALK variants was described previously [11] . Site-directed mutagenesis was carried out by the Quikchange procedure (Stratagene).
Protein expression and purification
His-tagged EML2 11-60 and EML4 6-64 I38M were expressed in B834 cells grown in Luria broth and SelenoMet Medium (Molecular Dimensions) respectively. The proteins were purified from clarified lysate in 50 mM HEPES pH 7.5, 500 mM NaCl using a nickel-charged 5 mL Chelating Sepharose column and eluted on a gradient from 50-500 mM imidazole. His-tags were ! 4! removed by digestion with tobacco etch virus (TEV) protease and the protein passed through a second Chelating Sepharose column. Finally, the proteins were gel filtrated into 10 mM Hepes pH 7.5, 80 mM NaCl, 2 mM dithiothreitol (DTT) on a Superdex 75 16/60 column (GE Healthcare).
Crystal structure determination
Crystals of EML4 6-64 I38M and EML2 11-60 were obtained by the hanging drop vapour diffusion method using 100 mM Tris/HCl pH 8.5, 30% PEG 4000, 200 mM MgCl 2 and 100 mM Bis-Tris-propane pH 6.5, 20% PEG 3350, 200 mM potassium thiocyanate respectively in the reservoir and were flash frozen in the same solutions with the addition of 20% glycerol and 5 mM DTT. Drops were formed from ~15 mg/mL protein solution mixed 1:1 with reservoir solution and incubated at 18°C for ~2 days.
Single-wavelength anomalous dispersion data to a resolution of 2.9 Å was collected from an EML4 6-64 I38M selenomethionine derivative crystal at Diamond I02. Diffraction images were indexed using imosflm [18] and scaled using scala! [19] . An initial map and model were obtained using PHENIX to locate selenium sites [20] revealing one trimer in the asymmetric unit. Manual rebuilding was carried out using COOT [21] . The 2.1 Å data was collected from a native EML2 11-60 crystal at Diamond I04. PHENIX was used to solve the structure of EML2 11-60 by molecular replacement phasing with the EML4 6-64 I38M structure, to automatically build the two trimers in the asymmetric unit, and for refinement.
In vitro MT-binding assays
Tubulin was prepared from pig brain as described previously [22] . Labeled tubulin was from Cytoskeleton Inc. YFP-EML1 proteins for use in in vitro microtubule binding assays were expressed as FLAG-Strep2 fusions in HEK293F suspension culture and purified from clarified cell lysate on Strep-tactin Sepharose (Qiagen) in Tris-buffered saline (TBS) and eluted using 3 mM desthiobiotin (IBA), followed by incubation with GST-tagged 3C protease to cleave off the tag and then passed over a Glutathione-sepharose column to remove the protease. Finally, the protein was separated from co-purifying tubulin by gel filtration on a Superose 6 column (GE Healthcare) in 20 mM Tris/HCl pH 7.5, 80 mM NaCl, 2 mM DTT before dialysis into MRB80 (80 mM PIPES, pH 6.8 with KOH, 1 mM EGTA, 4 mM MgCl 2 ) + 50 mM KCl and concentration to 20 µM. MT seeds were assembled from tubulin, biotin-tubulin and Hilyte647-tubulin at a molar ratio of 25:1:2 in the presence of 1 mM GMP-CPP in MRB80 for 1 hr at 37ºC, diluted 20-fold with MRB80 + 2 µM Taxol and stored at 21°C. A 100 µm deep flow chamber was made from a slide and a HCl-treated coverslip using double-sided Scotch tape (3M) and passivated with PLL-PEG-50% biotin (Susos AG). Seeds were attached to this surface using streptavidin and blocked with 1 mg/mL κ-casein (Sigma). A reaction mix containing 12 µM tubulin, 1 µM rhodamine-tubulin, 50 mM KCl, 1 mM GTP, 0.6 mg/ml κ-casein, 0.2% methyl cellulose, 4 mM DTT, 0.2 mg/mL catalase, 0.4 mg/mL glucose oxidase, 50 mM glucose in MRB80, supplemented with 500 nM YFP-EML1 protein or buffer was clarified for 8 min at 190,000xg in an airfuge (Beckman), the supernatant added to the flow chamber and sealed with candle wax. For MT-binding experiments in the absence of free tubulin the reaction mix was prepared as above but lacking tubulin and assays carried out using GMP-CPP stabilized MTs.
MTs were observed on an Olympus TIRF system with a 100x NA 1.49 objective, 488 nm, 561 nm and 640 nm laser lines and a Hamamatsu ImageEM-1k back-illuminated EM-CCD camera under the control of xcellence software. To quantify MT-bound YFP-EML1 proteins the average YFP-fluorescence intensity along a 3 pixel wide line along the MT was measured using ImageJ.
Cell culture and transfection
HeLa, HEK293 and U2OS cells were grown in Dulbecco's modified Eagle's medium (Gibco) supplemented with 10% heat-inactivated foetal bovine serum (FBS), 100 IU/mL penicillin and 100 µg/mL streptomycin at 37°C in a 5% CO2 atmosphere. EML constructs, EML1-ABL1 and EML4-ALK variants were cloned into pcDNA3 or pcDNA3.1-hygro (Invitrogen) with N-terminal YFP-or FLAG-tags. HeLa and HEK293 cells were transiently transfected with these plasmids using Fugene HD reagent (Promega) and U2OS cells using Lipofectamine 2000 (Invitrogen).
HEK293F cells were grown in suspension culture in Freestyle 293 medium (Gibco) in a 5% CO 2 atmosphere and transfected with Strep2-YFP-EML1 constructs in a modified version of pMAX (Lonza) at a density of 1x10 6 cells/mL using 2 µg/mL polyethylenimine.
NCI-H2228 cells were provided by Dr S Gray (Institute of Molecular Medicine, St James's Hospital, Dublin, Ireland); NCI-H3122 cells were obtained from the NCI Tumor Repository (Frederick, MD, USA). Cells were cultured in RPMI medium 1640, 2mM Glutamax and 10% Foetal Calf Serum (Gibco).
Fixed and live cell IF microscopy
For fixed cell microscopy, HeLa, H2228 and H3122 cells grown on acid-etched coverslips were fixed with ice cold methanol and processed for IF microscopy as described previously [23] , with the modification that cells were blocked for 30 min in 1x PBS supplemented with 1% bovine serum albumin and 0.2% Triton X-100. Primary antibodies used were 1 µg/mL anti-GFP ab6556 (Abcam), 0.3 µg/mL anti-α-tubulin (Sigma) and 1:200 anti-ALK D5F3 (Cell Signalling). Secondary antibodies were 1 µg/mL Alexa Fluor 488 conjugated goat anti-rabbit and Alexa Fluor 594 conjugated goat anti-mouse IgGs (Invitrogen). Cells were imaged using a Leica SP5 laser scanning confocal microscope. Deconvolution of image stacks was carried out using Huygens Essential software and the z-stacks were assembled in ImageJ. Quantitative image analysis performed with LAS-AF software (Leica) or ImageJ.
Western blot analysis
Primary antibodies for western blotting were mouse anti-FLAG M2 (Sigma) and rabbit anti-GFP ab6556 (Abcam). Secondary antibodies were horseradish peroxidase conjugated anti-mouse or anti-rabbit IgGs (GE Healthcare).
RESULTS
A conserved region in the EML N-terminus forms a trimerization domain
Proteins of the EML family contain regions N-terminal to the conserved TAPE core that are poorly conserved, often subject to splice variation and predicted to be mostly disordered. However, there is an island of conserved primary sequence within this region that is consistent with a coiledcoil ( Figure 1A) . To investigate the structural basis of self-association we crystallized protein fragments corresponding to this part of human EML2 and EML4 proteins. The structure was determined by single-wavelength anomalous dispersion phasing using crystals of a selenomethionine-labelled EML4 6-64 I38M mutant (Table 1, Figure 1B , Supplementary Figure  S1A ). Only residues 14-44 were visible in the electron density map but most strikingly they formed a trimeric coiled-coil. We then obtained 2.1 Å diffraction data using crystals of EML2 isoform 2 residues 11-60 and solved its structure by molecular replacement phasing (Table 1, Figure 1C , Supplementary Figure S1B ).
The EML trimerization domain (TD) forms an amphipathic α-helix with a series of nine conserved hydrophobic residues (predominantly leucine and valine) along the inner face whose side chains pack together into the core of the trimer (coloured yellow in Figure 1 ). A conserved glutamine (Gln29 in EML2, coloured grey in Figure 1D ) on the inner face makes hydrogen bond interactions with main-chain carbonyls in the core, perhaps serving to maintain the register of the coiled-coil. Interspersed between the hydrophobic residues in the sequence are conserved charged residues whose side chains are positioned to form salt-bridges with those of the adjacent protomers around the outside of the trimer (coloured light blue in Figure 1 ). The pattern of conserved residues indicates that human EML1-4 are all trimeric, as are their respective oncogenic fusion proteins ( Figure 1E ).
The trimerization domain is critical for EML self-association ! 6!
The most conserved surface patch in the TD is composed of several amino acids with short side chains (ALAD motif), which constrict the shape of the coiled-coil (Figure 2A ). We investigated whether the TD or disruption of the ALAD motif affect self-association in a representative member of the EML family, EML1. We tested the ability of various YFP-tagged EML1 constructs to coimmunoprecipitate with FLAG-tagged full-length EML1 from lysates of co-transfected HEK293 cells ( Figure 2B ). Full-length EML1 (FL), the isolated N-terminus (1-174) and a construct corresponding to residues 23-78 (trimerization domain; TD) co-immunoprecipitated with full-length EML1 while the TAPE region did not. A double mutation (L59A, D61A) in the most conserved motif in the TD (AAAA) did not disrupt self-association but deletion of the whole conserved region (Δ-TD) abrogated self-association completely.
The key residues involved in self-association within the trimerization domain are imperfectly conserved, and EML3 has the most divergent TD ( Figure 1E ). This observation prompted us to investigate whether EML3 could self-associate, and whether associations between EML3 and other members of the EML family could happen. We tested the ability of YFP-EML3 to coimmunoprecipitate with FLAG-EML1, FLAG-EML2 or FLAG-EML3 from lysates of co-transfected HEK293 cells ( Figure 2C ). YFP-EML3 co-immunoprecipitated with FLAG-EML3 and, more weakly, with FLAG-EML2, but not with YFP-EML1. This is consistent with the degree of conservation within the 17 key residues involved in self-association: EML1 and EML2 -12 identical, 5 conservatively substituted; EML1 and EML3 -6 identical, 5 conservatively substituted, 5 non-conserved; EML2 and EML3 -9 identical, 3 conservatively substituted, 5 non-conserved.
The trimerization domain is critical for MT binding
We confirmed co-localization of YFP-tagged human EML1 to the interphase MT network of transiently transfected HeLa cells, as has been previously observed for endogenous EML proteins (Figure 3) [5-8]. Overexpression of a tagged protein might affect its regulation and distribution on microtubules, and we shall not comment on these features of the data. However, this approach enabled us to screen the MT-binding properties of multiple YFP-EML1 constructs to identify which domains were needed for this activity ( Figure 3A) . The co-localization of YFP-EML1 proteins with MTs was visualised ( Figure 3B ) and quantified ( Figure 3C) .
The isolated N-terminal region (aa 1-174), which is not conserved at the sequence level for most of its length but includes the TD, strongly associated with MTs. However, neither the putatively disordered region lying between the TD and TAPE domains (74-174) nor the TD alone (23-78), nor the isolated TAPE domain were sufficient to associate with MTs in cells. Deletion of the TD from EML1 considerably reduced its interaction with MTs in cells, whereas mutation of the ALAD motif within the TD decreased MT co-localization modestly. The overexpressed EML1 proteins might interact directly with MTs, through association with endogenous EML1 or other EMLs, or indeed through associations with other MAPs. To distinguish between these different modes of interaction, direct binding of recombinantly expressed and purified YFP-EML1 protein constructs to purified MTs was measured in vitro by total internal reflection fluorescence (TIRF) microscopy (Figure 4) . Here, direct association of full-length EML1 and the N-terminal region with MTs was measured, whereas the isolated TAPE domain did not associate ( Figure 4A,C) ; fulllength EML1 with a mutated ALAD motif exhibited reduced binding compared to wild-type, and the deletion of the TD abolished MT interaction altogether ( Figure 4B,D) .
Taken together, the results from the cell-based and in vitro MT-binding assays demonstrate that the N-terminal region of EML1 confers MT binding and that the TD is required. However, the TD is not sufficient for MT association, which requires other sequences in the N-terminal region.
EML4-ALK variant 3 localizes to MTs
Having identified the N-terminus as a MT-binding region of EML proteins, and recognising that it is intact in many of the fusion oncoproteins, we supposed that the fusion oncoproteins might be targeted to MTs. We examined HeLa cells transfected with YFP-tagged EML-tyrosine kinase ! 7! fusions ( Figure 5A -C) and found that this was not generally the case: EML4-ALK variants 1 and 2 and EML1-ABL1 form cytoplasmic aggregates and EML4-ALK variant 5a is diffusely localized in the cytoplasm, while only EML4-ALK variant 3a was localized to MTs. Next we investigated by immunofluorescence microscopy the localization of the endogenous EML4-ALK fusion proteins in two patient-derived NSCLC cell lines, H3122 and H2228 ( Figure 5D-F) . The variant 1 protein present in H3122 cells displayed a patchy appearance in the cytoplasm consistent with a protein that is largely aggregated but the variant 3b protein in H2228 cells was localized to the MT network.
Taken together, these results show that the N-terminal domain of EML4 is able to confer MT localization on EML4-ALK variant 3, but not when a truncated part of the EML4 TAPE domain is present as in variants 1 and 2. ! 8!
DISCUSSION
Association of the EML1 N-terminal region with MTs requires both the TD and the ~90 residue region between the TD and TAPE domains. This latter, putatively disordered, inter-domain region is not conserved at the sequence level but contains many basic residues. The TD presumably enhances binding of EML proteins to MTs through an avidity effect, and may contribute directly to the interaction through a conserved surface region that is disrupted by the AAAA mutation.
EML oncogenic fusions such as EML4-ALK and EML1-ABL1 are naturally occurring and exist in a context in which the MT binding properties of the EML N-terminus are isolated from the TAPE region. In EML4-ALK variant 3a/b the whole of the EML4 N-terminal region, and evidently its MT-binding activity, is transferred to the fusion protein ( Figure 6 ). EML4-ALK variant 5 has a TD, but lacks the basic region, and is therefore incapable of binding to MTs. The other EML4-ALK variants and EML1-ABL1 contain a complete N-terminus encompassing the TD and basic region, and might be expected to localize to MTs, but do not. In these cases, it appears that the presence of a partial TAPE domain interferes with MT binding, perhaps through protein misfolding leading to aggregation into complexes with Hsp90 that may sterically block MT association. Indeed, the microscopy studies of several of the EML-kinase fusions, including endogenous EML4-ALK variant 1 in H3122 cells, were consistent with aggregation of these proteins. Furthermore, we have previously shown that EML4-ALK variants 1 and 2 are more sensitive to Hsp90 inhibitors than variants 3 and 5 [11] .
The EML2 and EML4 TD structures presented here reveal that EML proteins and EML4-ALK oncoproteins self-associate as trimers through a specific and stable coiled-coil interface. The more widely expressed isoform 1 of EML2 does not possess a TD region and is therefore unlikely to interact directly with other EMLs but a TD is present in the brain/spinal cord variant isoform 2 studied here! [24] . EML3 can also self-associate, and can interact with EML2 isoform 2, but not with EML1. The functional relevance of interactions between EML family members is not clear, but the potential for these interactions should be borne in mind during functional studies.
It is notable that the more divergent human paralogues, EML5 and EML6, lack coiled-coil regions but have three copies of the TAPE region each. Thus, the quaternary structure of all six human EML proteins may feature three TAPE regions ( Figure 6A ). In oncogenic ALK-fusions oligomerization conferred by the fusion partner mimics the native oligomerization-dependent activation mechanism of receptor tyrosine kinases and engenders constitutive activation of ALK [25] . The use of rationally-designed peptide and peptidomimetic inhibitors is under investigation for the disruption of several coiled-coil interactions that are implicated in disease and clinically useful therapeutics have been developed using this approach [27, 28, 29] . The TD structures may enable the development of protein-protein interaction inhibitors targeting the trimerization interface of the EML4 TD, another possible avenue towards therapeutic intervention in EML4-ALK NSCLC and one that would be applicable to all variants. Sequence conservation mapped onto the surface of the EML2 TD structure; residues that are identical among human EML proteins are coloured red and highly conserved residues are coloured orange. (B) Immunoblot analysis of EML1 self-association. HEK293 cells were co-transfected with FLAG-EML1 and various YFP-EML1 constructs as indicated (top two panels). Proteins were immunoprecipitated using anti-FLAG M2 (Sigma) (lower two panels). Cell extracts were prepared as previously described [26] and analysed by SDS-PAGE and western blotting using anti-FLAG M2 and anti-GFP antibodies. (C) EML3 association with EML1-3. U2OS cells were co-transfected with YFP-EML3 and FLAG-EML1-3 as indicated. Immunoprecipitation and analysis was carried out as in (B). Supplementary Figure S1 
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